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ABSTRACT
Objective: To assess the effectiveness of models of
antenatal care designed to prevent and reduce preterm
birth (PTB) in pregnant women.
Methods: We conducted a search of seven electronic
databases and reference lists of retrieved studies to
identify trials from inception up to July 2014 where
pregnant women, regardless of risk factors for
pregnancy complications, were randomly allocated to
receive an alternative model of antenatal care or routine
care. We pooled risks of PTB to determine the effect of
alternative care models in all pregnant women. We also
assessed secondary maternal and infant outcomes,
women’s satisfaction and economic outcomes.
Results: 15 trials involving 22 437 women were
included. Pregnant women in alternative care models
were less likely to experience PTB (risk ratio 0.84, 95%
CI 0.74 to 0.96). The subgroup of women randomised
to midwife-led continuity models of antenatal care were
less likely to experience PTB (0.78, 0.66 to 0.91) but
there was no significant difference between this group
and women allocated to specialised care (0.92, 0.76 to
1.12) (interaction test for subgroup differences
p=0.20). Overall low-risk women in alternative care
models were less likely to have PTB (0.74, 0.59 to
0.93), but this effect was not significantly different
from that in mixed-risk populations (0.91, 0.79 to 1.05)
(subgroup p=0.13).
Conclusions: Alternative models of antenatal care for
all pregnant women are effective in reducing PTB
compared with routine care, but no firm conclusions
could be drawn regarding the relative benefits of the
two models. Future research should evaluate the
impact of antenatal care models which include more
recent interventions and predictive tests, and which
also offer continuity of care by midwives throughout
pregnancy.
PROSPERO registration number:
CRD42014007116.
INTRODUCTION
Preterm birth (PTB) is the term used to
deﬁne births that occur before 37 completed
weeks of gestation.1 More than 1 in 10 babies
worldwide are born prematurely every year,
for an estimated 15 million PTBs, of which
over one million die annually from complica-
tions of their prematurity.2 Many of the
babies who survive face greater risks of sig-
niﬁcant health problems and disability
throughout their lives (ie, learning disabil-
ities, visual and hearing problems, chronic
lung disease and other long-term diseases),3
which translate into signiﬁcant increased
costs to healthcare, the economy and the
broader society.4
Despite numerous efforts to decrease its
prevalence, improve clinical management
and reduce neonatal morbidity and mortality,
PTB rates continue to rise in most countries
with reliable data.5 A wide variety of predis-
posing factors have been associated with PTB
such as infections; social stress and intimate
partner violence; non-Caucasian ethnic
groups and other maternal factors (eg,
Strengths and limitations of this study
▪ This study is the first systematic review and
meta-analysis to evaluate the efficacy and safety
of existing models of antenatal care as a means
of reducing preterm birth (PTB) rates in all preg-
nant women.
▪ Our study provides evidence from 15 rando-
mised controlled trials with 22 437 participants.
Comprehensive search strategies with no restric-
tions on publication date, country or language
mean it is unlikely trials were missed.
▪ Compared to routine care, alternative models of
antenatal care were associated with a significant
reduction in the risk of PTB (16%). We per-
formed subgroup analyses and sensitivity ana-
lyses, and assessed whether effects were
different for low and mixed risk women and dif-
ferent models of antenatal care (midwife-led con-
tinuity of care and specialised antenatal care).
▪ Lack of high quality and substantial heterogen-
eity in some of the trials may have an influence
on the power of this study.
▪ Lack of consistency in measuring and reporting
women’s experience and health economic eva-
luations can make them difficult to assess and
report maternal satisfaction and economic costs.
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young or advanced age; previous PTB; short inter-
pregnancy intervals; nutritional deﬁciencies, cervical
procedures; underlying medical conditions; smoking
and alcohol consumption).6 This complex and multifac-
torial nature of PTB is likely responsible for single inter-
ventions not demonstrating a signiﬁcant public health
effect.7 However, there is a paucity of appropriately and
efﬁcaciously designed antenatal care packages for pre-
maturity, and it remains a top research priority for PTB.8
We aimed to analyse, quantify and evaluate the effect-
iveness of existing or promising interventions delivered
as an integrative package of antenatal care or models of
care as a means of reducing PTB rates in all pregnant
women, regardless of risk factors for pregnancy and
birth complications. Our secondary objective was to
assess their impact on antenatal hospitalisation, breast-
feeding initiation, caesarean birth, induction of labour,
instrumental vaginal delivery (forceps/vacuum), mater-
nal satisfaction, spontaneous vaginal birth (as deﬁned by
trial authors), Apgar score ≤7 at minute ﬁve, admission
to special care/neonatal intensive care unit (NICU),
length of neonatal stay (mean length in days), low birth-
weight (<2500 g), fetal loss/neonatal death before and
after 24 weeks, and overall fetal loss and neonatal
deaths. Additionally, we aimed to perform subgroup ana-
lyses and sensitivity analyses of the main outcome (PTB)
and to assess whether effects were different for low and
mixed risk women and different models of antenatal
care, and synthesise data on women’s experiences and
economic outcomes reported in the above trials.
METHODS
Search strategy and selection criteria
We conducted a systematic review of the effect of models
of antenatal care on PTB according to Preferred
Reporting Items for Systematic reviews and
Meta-Analyses (PRISMA) guidelines9 (see ﬁgure 1). We
comprehensively searched the following electronic data-
bases, with no language, setting or time limits set, for
published studies up to 14 June 2014: MEDLINE,
EMBASE, CINAHL, CENTRAL, BNI, PsycINFO, and
WEB of SCIENCE. Limitations to females and humans
were applied to each database and highly sensitive
search ﬁlters were used to identify reports of rando-
mised controlled trials (RCTs).10 Search terms, keywords
and strategies, which were reviewed by an information
specialist in medicine, are detailed in online supplemen-
tary appendix 1. We also hand-searched bibliography
Figure 1 PRISMA Flow
Diagram of Included Studies.
PRISMA, Preferred Reporting
Items for Systematic reviews and
Meta-Analyses.
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and reference lists of the studies identiﬁed and other
reviews to locate further studies and the Australian New
Zealand Clinical Trials Registry and the US
ClinicalTrials.gov register for unpublished and ongoing
trials.
We included studies of pregnant women who were
classiﬁed as being at low or high risk of pregnancy com-
plications and/or PTB, regardless of their age, ethnicity,
socioeconomic status or presence of comorbid condi-
tions at enrolment. Studies using alternative models of
antenatal care compared with standard care as a control
were included. The intervention had to involve the
organisation and provision of either comprehensive
antenatal care or components of antenatal care deliv-
ered in the context of normal antenatal care. We
included midwife-led continuity models of care, PTB
prevention programmes, clinic-based specialised care
and stand-alone interventions involving the provision of
health or social care delivered in conjunction with stand-
ard antenatal care. No limitations were set regarding the
professional who delivered the intervention. We
excluded studies of stand-alone interventions or speciﬁc
clinical and medical interventions targeting pregnant
women, unless evaluated in the context of an integrated
antenatal care package. Owing to existing reviews,
studies of group prenatal care and packages of commu-
nity care which did not include clinical care were
excluded. Only studies that reported at least the main
outcome measure of interest (PTB before 37 completed
weeks’ gestation as the standard cut-off point) were
included in the meta-analysis.
We selected studies in two stages. First, titles and
abstracts were screened by one author (CFT) who
excluded citations that were not related to RCTs or any
model of antenatal care; second, the full text of poten-
tially relevant studies was checked in a non-blinded, stan-
dardised manner, by a second reviewer ( JS). The
Cochrane Validity Inclusion Criteria was used to reassess
the validity of the study design and the methodological
details to determine whether the study should be
included in the review11 (see online supplementary
appendix 2). Final selections were based on consensus
reached though discussion between the two reviewers.
Data extraction of the eligible studies was conducted
using a predesigned template form. Two review authors
(CFT and JS) independently extracted the data using
the agreed form and any discrepancies were easily
resolved though discussion. We used the Review
Manager (RevMan) software V.5.312 to double enter all
the data. Thirty items of data were extracted from each
study including details of settings, baseline character-
istics of participants, details of experimental and control
interventions, inclusion and exclusion criteria of the
study participants, details of the risk assessment criteria
used to identify women at low or high risk of PTB,
number of total participants, loss to follow-up, and
details regarding the deﬁnition of PTB as described by
each study to validate the PTB outcome measurement,
or if relevant, units of measurement. When information
regarding any of the above was unclear, we contacted
authors of the original studies to provide further details.
For characteristics of included and excluded studies, see
online supplementary appendices 3 and 5.
Quality assessment
We used the criteria outlined in the Cochrane Handbook
of Systematic Review of Interventions13 to make explicit jud-
gements regarding whether or not the studies were at
low or high risk of bias. The ﬁrst reviewer (CFT) inde-
pendently assessed and presented individual speciﬁc
domains, including random sequence generation, alloca-
tion concealment, blinding, incomplete outcome data
and selective reporting. Then, quality assessments were
double-checked by a second reviewer ( JS), and any dis-
crepancies were resolved by discussion (see online sup-
plementary appendix 6).
Statistical analysis
The general meta-analytic approach was as follows.
Outcomes from different trials were pooled where they
were measured in the same way and random-effects
pooled estimates were calculated throughout due to the
nature and complexity of the interventions14 using
RevMan.12 Dichotomous data are presented as pooled
risk ratios (RR) with 95% CI and continuous data as
summary mean difference (MD) with 95% CI.
We used the Cochrane Handbook13 as a guide to deal
with the approximate analyses of a cluster trial15–19
included in the analysis. However, because an estimate
of the intracluster correlation coefﬁcient (ICC) was not
provided for this study, a published ICC from another
antenatal care trial was used20 alongside a sensitivity ana-
lysis to check the effect of varying the ICC was per-
formed with to compare the two methods (see online
supplementary appendix 7).
Statistical heterogeneity was assessed using τ2, I2 and
χ2 statistics with its equivalent p value. Heterogeneity was
regarded as substantial if I2 >30% and either if τ2 >0 or
p<0.10. Potential sources of heterogeneity were investi-
gated using subgroup analyses testing by ﬁtting an inter-
action term. Subgroup analyses were stipulated a priori
according to the review’s main outcome, PTB and per-
formed by type of intervention (midwife-led continuity
models of care vs specialised antenatal care) and by
level of risk status of the participants (low vs mixed risk).
Funnel plots were used to examine reporting/publica-
tion bias where there were 10 or more studies for an
outcome.
Study factors were used in sensitivity analyses to evalu-
ate the impact of the methodological quality on the
overall results. For the purpose of this review, studies
were particularly considered to be of high quality if they
used adequate methods of generating the allocation
sequence and concealment and had an attrition rate
<20%.
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Maternal experience and economic costs of the ante-
natal care models were only reported narratively in due
to a lack of consistency in measuring and assessing such
outcomes.
RESULTS
Search strategies of the electronic databases and add-
itional resources elicited a total of 13 351 citations,
leaving 11 106 unique studies after duplicates were
removed. Following title and abstract screening, the
remaining 187 studies were selected for full-text assess-
ment of eligibility. One hundred and sixty-ﬁve studies
were excluded and another four studies were added
from the reference and bibliography lists of the
screened studies. Subsequently, of the 22 included
studies assessed for validity, only 15 studies met the
inclusion criteria for data analysis. The appendix lists
include the validity assessments and reasons for
exclusion.
We included a total of 15 RCTs15–19 21–48 involving
22 437 women that were conducted in four countries in
a wide variety of settings and health systems. The Zelen
method was used in one trial,27 one study used multicen-
tre cluster randomisation,15–19 and three other studies
used multicentre individual randomisation.24 26 27 40 41
All of the included studies involved women classiﬁed as
low-risk or mixed-risk for complications, and alternative
models of antenatal care, which included either
midwife-led continuity of care models or specialised
antenatal care models.
Midwife-led continuity of antenatal care can be
deﬁned as the care where the midwife is the lead profe-
sional in the planning, organisation and delivery of ante-
natal care given to a woman throughout her pregnancy.
Some antenatal care may be provided in consultation
with medical staff as appropriate. However, the compos-
ition, level of continuity and modus operandi of teams
in midwife-led models varied among trials. Midwife-led
continuity care models were compared to shared ante-
natal care models led by different healthcare profes-
sionals,21 22–23 37 38–39 to medical-led models of care led
by obstetricians,29 42–46 and to various options of stand-
ard antenatal care, including rostered midwife-led,
medical-led and shared care.32–36 47 48 Specialised care
studies focused mainly on the value of specialised ante-
natal clinics for pregnant women identiﬁed at increased
risk of PTB compared with standard antenatal clinic
attendance. The studies compared the alternative care
models with routine antenatal care provided by obstetri-
cians, general practitioners (GPs), or both, in collabor-
ation with midwives and nurses.24–28 30 31 A summary of
the characteristics of included studies is presented in
table 1A, B.
A few trials excluded women who were at more than
24 weeks’ gestation, more than 30 weeks’ gestation,25 or
more than 32–34 weeks’ gestation.24 Women with a mul-
tiple pregnancy or a planned elective caesarean section
were excluded from two trials.30 31 38 39 Some studies
excluded women with substance abuse problems,28 37 or
attempted suicide during pregnancy.15–19 Other studies
excluded women with complex general medical condi-
tions (ie, epilepsy, diabetes, cancer, HIV/AIDS or
cardiac disease);15–19 28 or women with previous
small-for-gestational-age babies, stillbirth or neonatal
death.30 31 Online supplementary appendices 3, 4 and 8
include detailed characteristics of included studies,
reported outcomes of interest and a brief description of
the risk assessment criteria used to classify the women’s
risk status. All of the 15 included studies used the WHO
deﬁnition criteria when stating the main outcome of this
review (PTB).1
Effects of alternative models of antenatal care versus
routine care for all pregnant women
Compared to women in routine care groups, pregnant
women in alternative models of antenatal care were, on
average, less likely to experience PTB <37 weeks (RR
0.84, 95% CI 0.74 to 0.96) (ﬁgure 2). In addition, these
women are, on average, less likely to experience a cae-
sarean birth (RR 0.92, 95% CI 0.85 to 1.00) and induc-
tion of labour (RR 0.90, 95% CI 0.81 to 0.99); and more
likely to experience spontaneous vaginal birth (as
deﬁned by the trial authors) (RR 1.05, 95% CI 1.01 to
1.10) (see online supplementary ﬁgures 9.3, 9.4 and 9.6
in appendix 9). There were no statistically signiﬁcant dif-
ferences between alternatives care models and routine
care groups in any of the remaining outcomes (see
online supplementary ﬁgures 9.1, 9.2, 9.10–9.14, 9.17
and 9.18 in appendix 9). Table 2 presents a summary of
the meta-analysis on maternal and neonatal outcomes of
interest.
There was substantial heterogeneity in many of the
analyses. The I2 value was greater than 50% for six out-
comes—breastfeeding initiation, induction of labour,
spontaneous vaginal birth, low birthweight and mean
length of neonatal hospital stay—and greater than 30%
for PTB. However, little or non-signiﬁcant heterogeneity
was observed between studies in the remaining out-
comes. There was slight asymmetry in the funnel plot
for PTB (ﬁgure 3) due to a small trial with small
number of events and large treatment effects.47 48 Other
funnel plots were mostly symmetrical, providing little
overall evidence for publication bias (see online supple-
mentary ﬁgures 9.19, 9.21 and 9.22 in appendix 9).
Subgroup analysis of effects of different antenatal care
models and mixed risk and low-risk populations of women
on PTB outcome
There was a signiﬁcant effect of midwife-led continuity
care models on reducing PTB in the intervention group
(RR 0.78, 95% CI 0.66 to 0.91), while specialised care
models were not signiﬁcant (RR 0.92, 95% CI 0.76 to
1.12) However, the interaction test shows that these two
relative risks are not signiﬁcantly different from each
other (p=0.20) (ﬁgure 4). Similarly, there was no
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Table 1 Characteristics of included studies
Baseline characteristics Summary of participants
Age of
participants
Gestation at
first visit
Socioeconomic
status and/or
education level*
Participants included
in the study
Allocation of
participants
Multiple
pregnancies
Loss to
follow-up
Study ID: major
publication Country Years
Mean±SD or
age groups
(%) Mean±SD Ethnicity (%)
Marital
status:
married (%) Trends
Other health
behaviours (%) Type Classification Number
Intervention
group
Control
group Number (%)
Number
(%)
Begley et al21 Ireland 2004–2007 30±4.9 NA NA 58% Higher NA Low risk Low risk 1653 1101 552 NA 8 (0.5%)
Biro et al22 Australia 1996–1998 28±5.3 14±2.8 NA 70% Lower Smokers 35% Low and
high risk
Mixed risk 1000 502 498 25 (2.5%) 32 (3.2%)
Collaborative
group 199324
USA 1983–1986 NA NA Black: 44.2%
Hispanic: 15.1%
White: 39.7%
NA Lower NA High risk Mixed risk 2395 1200 1195 132 (10.7%) NA
Goldenberg
et al25
USA 1982–1986 <20: 36%
20–34: 60%
≥34 : 4.2%
NA Black: 72%
White: 27.7%
A minority Lower NA High risk Mixed risk 969 491 478 37 (7.7%) NA
Hobel et al15 USA 1983–1988 26±5.6 19±7.1 Black: 8.2%
Hispanic:75.5%
White: 13.5%
Asian: 4.4%
55% Lower NA High risk Mixed risk 2654 1174 880 19 (0.8%) <10%
Iams and
Johnson 26
USA 1983–1986 NA NA White and African
American
NA NA NA High risk Mixed risk 370 182 188 NA NA
Klerman et al28 USA 1994–1996 16–19: 29%
20–29: 61%
≥30: 11%
10±4.5 African-
American:100%
7% Lower Smokers 21% High risk Mixed risk 619 318 301 NA NA
MacVicar et al29 UK 1989–1991 25±4.5 NA NA NA NA Smokers 28% Low risk Low risk 3510 2304 1206 NA NA
Main et al30 USA 1983–1986 24±5.3 12.2±3.4 Black: 100% NA Lower NA High risk Mixed risk 943 198 178 0 (0%) NA
McLachlan
et al32
Australia 2007–2010 31±4.7 16.3±2.8 NA 95% Higher Smokers 3.5% Low risk Low risk 2314 1156 1158 NA 7 (0.3%)
Rowley et al37 Australia 1991–1992 26±2.3 NA White: >90% >50% Higher Smokers <50% Low and
high risk
Mixed risk 814 405 409 13 (1.6%) NA
Tracy et al38 Australia 2008–2011 31±4.9 NA NA NA Higher NA Low and
high risk
Mixed risk 1748 871 877 0 (0%) 45 (2.5%)
Tucker et al40 UK 1993–1994 25±0.3 12.2±0.2 NA 34% NA Smokers 30% Low risk Low risk 1765 878 877 NA 91 (5.5%)
Turnbull et al42 UK 1993–1994 26±5.0 NA NA 54% Lower Smokers 38% Low risk Low risk 1299 648 651 NA 21 (1.6%)
Waldenström47 Australia 1996–1997 28±5.2 12.2±4.2 NA 89% Higher Smokers 37% Low risk Low risk 1000 495 505 6 (0.6%) 20 (2%)
Summary of interventions
Content of intervention
Study ID: major
publication Type
Antenatal care.
Frequency of visits
Cervical
examinations
Health
Education Psychosocial support and/or others Delivery Setting
Begley et al21 Midwife-led continuity
model of care
Yes. Routine visits or more depending on
complications
Midwives (GPs if desired) Hospital based and out-reach
clinics
Biro et al22 Midwife-led continuity
model of care
Yes. Routine visits or more depending on
women’s risk status
Midwives Hospital-based clinic
Collaborative Group
199324
Specialised care Yes. Weekly visits from 20 to 24 weeks’ until
delivery
Yes Yes Specialist nurses and medical staff Community-based clinic
Goldenberg et al25 Specialised care Yes. Weekly visits from 22 weeks until
delivery
Yes Yes. Specially trained nurses Community-based clinic
Continued
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Table 1 Continued
Summary of interventions
Content of intervention
Study ID: major
publication Type
Antenatal care.
Frequency of visits
Cervical
examinations
Health
Education Psychosocial support and/or others Delivery Setting
Hobel et al15 Specialised care Yes. Biweekly visits until delivery Yes. Yes. Psychosocial and nutritional
counselling. Secondary interventions
(bed rest, psychosocial support, oral
progestin, or a placebo)
Nurses, health educators,
nutritionists
Community-based clinic
Iams and Johnson26 Specialised care. Yes. Weekly visits from 20–36 weeks Yes Yes Not clearly stated Specialised clinic
Klerman et al28 Specialised care. Yes. Biweekly visits until 36 weeks’ gestation,
then weekly
Yes Yes. Group sessions: pregnancy, peer
social support, healthy behaviours.
Nurses and trained community
experienced workers
Community-based clinic
MacVicar et al29 Midwife-led continuity
model of care
Yes. Routine visits (one to three visits) Midwives Hospital-based clinic
Main et al30 Specialised care, Yes. Weekly or biweekly visits from 22 weeks
to birth
Yes Yes Physicians and specialists nurses Hospital based specialised
clinic
McLachlan et al32 Midwife-led continuity
model of care
Yes. Routine visits (one to three visits) Caseload midwives Community-based clinic.
Rowley et al37 Midwife-led continuity
model of care
Yes. Routine visits (one to three) or more
depending on risk status
Midwives Hospital-based clinic
Tracy et al38 Midwife-led continuity
model of care
Yes. Routine visits or more depending on risk
status
Caseload midwives Community-based clinic
Tucker et al40 Specialised care Yes. Visits arranged according to detailed
care plans
GP and community midwives Community-based clinic
Turnbull et al42 Midwife-led continuity
model of care
Yes. Routine visits or more depending on
arising complications
Caseload midwives Community-based clinic
Waldenström et al47 Midwife-led continuity
model of care
Yes. Routine visits or more depending on
arising complications
Midwives Hospital-based clinic
*Trend toward lower or higher socio-economic status and education levels across study participants.
GP, general practitioners; NA, not applicable or not reported.
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evidence that the effect in low-risk women while signiﬁ-
cant on its own (RR 0.74 95% CI 0.59 to 0.93), differed
signiﬁcantly (p=0.13) from that in mixed risk women
(RR 0.91 95% CI 0.79 to 1.05) (ﬁgure 5).
Sensitivity analysis
A sensitivity analysis was performed for the PTB
outcome by using the upper 95% CI for the ICC
(0.0041). Thus, the weight of the study was reduced
from 7.6% to 6.7%. However, this adjustment made very
little difference, and the overall results remained signiﬁ-
cant with substantial heterogeneity (RR 0.83, 95% CI
0.72 to 0.95) (see online supplementary ﬁgure 9.8 in
appendix 9). Similarly, the sensitivity analysis performed
for the low birthweight outcome by using the upper
95% CI for the ICC (0.0016) reduced the weight of the
study from 11% to 10.5%, but the overall intervention
effect was not signiﬁcant (RR 0.82, 95% CI 0.60 to 1.12),
and subgroup differences remained statistically signiﬁ-
cant in the presence of substantial heterogeneity (see
online supplementary ﬁgure 9.15 in appendix 9).
Overall, the sensitivity analysis for PTB including only
high-quality studies21–23 32–36 38–46 did not alter the
results for the main outcome, which remained consist-
ent with the overall ﬁndings. Studies rated at high risk of
bias were excluded in the sensitivity analysis in order to
assess for any substantive difference to the overall ﬁnd-
ings (see online supplementary ﬁg 9.23 in appendix 9).
Maternal experience and satisfaction and economic
analysis
The lack of consistency in measuring and reporting
women’s experience and satisfaction and health eco-
nomic evaluations, makes the presentation of a narrative
synthesis of such data much more feasible.13 Seven
studies reported maternal satisfaction with diverse ele-
ments of the antenatal experience.23 28 29 37 40–48
Considering the ambiguity associated with the concept
of satisfaction, it was expected to ﬁnd inconsistencies in
the instruments, scales, timing and outcomes used to
‘measure’ women’s experiences with antenatal care
across studies. Maternal experience and satisfaction was
considered with information, explanation, advice, dur-
ation of antenatal visits and participation in decision-
making. One study28 assessed also perceptions of ante-
natal risks, including PTB risk, reported behavioural
changes and degree of control over events in the partici-
pants’ lives (perceived mastery) using three—and four
—point scales. The overall satisfaction indicators and
rating scores, which directly related to both provider atti-
tude and/or women, are presented as tabulated results
for easy understanding and convenience in online sup-
plementary appendix 10. In brief, most of the included
studies showed higher satisfaction levels with antenatal
care in both alternative models (midwife-led continuity
care and specialised care) when compared to routine
antenatal care.
Six studies included in this review provided an eco-
nomic analysis, including various items and measures in
the ﬁnal cost estimation; however, one of the studies
included only inpatient maternity care, excluding ante-
natal or postnatal care cost estimation.37 In summary,
only ﬁve studies presented maternity cost data of
interest, using diverse methods for economic evalu-
ation.15–19 30 31 38–46 The analysis of two included studies
suggested a higher cost of antenatal care programmes
designed for high-risk women,15–19 30 31 and the analysis
of three included studies suggested a cost-saving effect
Figure 2 Forest plot comparing preterm birth (<37 weeks) between pregnant women receiving alternative models of antenatal
care and those receiving routine care—adjusted for cluster design effect (ICC 0.002). ICC, intracluster correlation coefficient.
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in midwifery-led care compared to standard shared
care.38–46 Overall, there was a lack of consistency among
the available studies in estimating the costs of antenatal
care; however, there appears to be a trend appears
towards the cost-saving effects of midwife-led continuity
of antenatal care compared with specialised care.
Economic costs of the antenatal care models in included
studies are reported narratively in detail in online sup-
plementary appendix 11.
DISCUSSION
The results of our main review comparison indicated
that the risk of PTB <37 weeks in pregnant women who
received alternative antenatal care models was reduced
by 16%, compared with women who received routine
care. In addition alternative antenatal care models were
associated with reductions in risk of induction of labour
(by 10%) and caesarean birth (by 8%) and with
increased likelihood of spontaneous vaginal birth (by
5%). These results were robust to various sensitivity ana-
lyses. There was no evidence that any alternative model
of antenatal care was associated with an increased likeli-
hood of adverse outcomes for women or their infants.
Instrumental vaginal delivery and fetal loss before
24 weeks were less likely in women receiving alternative
antenatal care models but were not statistically
signiﬁcant.
There were considerable variations in the interven-
tions and participants across studies and so interpreting
Table 2 Summary of data analysis on outcomes of interest
Outcome
Studies
(N) Participants Pooled RR (95% CI)
I2
(%)
p
Value
Primary outcomes
Antenatal hospitalisation 4 5187 1.02 (0.93 to 1.11) 15 0.72
Breastfeeding initiation 3 5067 1.01 (0.95 to 1.08) 56 0.75
Caesarean birth 11 15 919 0.92 (0.85 to 1.00) 2 0.04
Induction of labour 9 14 924 0.90 (0.81 to 0.99) 59 0.03
Instrumental vaginal delivery (forceps/vacuum) 9 14 924 0.93 (0.86 to 1.01) 0 0.08
Preterm birth (<37 weeks)—adjusted for cluster
design effect (ICC 0.002)
15 0.84 (0.74 to 0.96) 49 0.01
Individualised randomised trials 14 0.84 (0.73 to 0.97)
Cluster randomisation 1 0.83 (0.59 to 1.16)
Preterm birth (<37 weeks)—sensitivity
analysis (ICC 0.0041)
15 0.83 (0.72 to 0.95) 51 0.007
Individualised randomised trials 14 0.84 (0.73 to 0.97)
Cluster randomisation 1 0.69 (0.47 to 1.02)
Preterm birth (<37 weeks)—all studies,
unadjusted data
15 22 437 0.86 (0.76 to 0.97) 42 0.01
Individualised randomised trials 14 19 783 0.86 (0.75 to 0.98)
Cluster randomisation 1 2654 0.81 (0.62 to 1.06)
Spontaneous vaginal birth (as defined by trial authors) 9 14 924 1.05 (1.01 to 1.10) 65 0.01
Secondary outcomes
5-min Apgar score ≤7 9 10 779 0.86 (0.68 to 1.09) 0 0.21
Admission to special care unit/NICU 11 15 225 0.94 (0.84 to 1.05) 15 0.25
Fetal loss/ neonatal death before 24 weeks 9 14 968 0.81 (0.65 to 1.02) 0 0.07
Fetal loss/ neonatal death equal to/after 24 weeks 8 13 294 0.97 (0.60 to 1.58) 0 0.91
Low birthweight (<2500 g)—adjusted for cluster
design effect (ICC 0.0003)
10 0.83 (0.61 to 1.13) 85 0.23
Individualised randomised trials 9 0.77 (0.55 to 1.09)
Cluster randomisation 1 1.38 (1.00 to 1.92)
Low birthweight (<2500 g)—sensitivity
analysis (ICC 0.0016)
10 0.82 (0.60 to 1.12) 78 0.22
Individualised randomised trials 9 0.77 (0.55 to 1.09)
Cluster randomisation 1 1.36 (0.92 to 2.00)
Low birthweight (<2500 g)—all studies,
unadjusted data
10 17 992 0.98 (0.89 to 1.09) 0 0.76
Individualised randomised trials 9 15 338 0.99 (0.89 to 1.11)
Cluster randomisation 1 2654 0.91 (0.67 to 1.25)
Mean length of neonatal hospital stay (days)
MD (95% CI)
3 2027 −2.11 (−4.64 to 0.41) 69 0.10
ICC, intracluster correlation coefficient; MD, mean difference; NICU, neonatal intensive care unit; RR, risk ratios.
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the ﬁndings of these main comparisons was not straight-
forward. Trends in subgroup analyses suggested that the
type of intervention and women’s risk status might inﬂu-
ence the effectiveness of the intervention, but the results
were not statistically signiﬁcant. Compared with studies
of midwife-led continuity care, most specialised clinic
studies provided little data on the outcomes of interest,
with the exception of PTB. In fact, the overall beneﬁcial
effects of PTB, spontaneous vaginal birth, induction of
labour, and caesarean birth, were obtained from an ana-
lysis of midwife-led continuity of care studies. The obser-
vation that pregnant women allocated to midwife-led
continuity care models were less likely to experience
PTB compared to women allocated to specialised clinic
care is potentially important given the global interest in
preventing PTB4 49 but this observed beneﬁt was not
statistically different from that observed for specialised
care. Hence though while no ﬁrm conclusions can be
drawn, the issue remains important due to the growing
focus on specialised clinics to deal with the increasing
complexity of managing women at high risk despite the
paucity of evidence to support their beneﬁt.50 It is pos-
sible that existing clinical interventions aimed at the pre-
vention of PTB might depend on fast access to care,
which is potentially inﬂuenced by midwifery continuity
of care.51 This would be consistent with the observation
that low-risk and mixed-risk women in midwife-led care
models have a lower risk of PTB.
The observed results might also be partially explained
by the varying type, content or delivery of the interven-
tion. All studies of specialised PTB clinics included
weekly or biweekly antenatal visits throughout the preg-
nancy and included detailed education regarding
preterm labour onset signs and symptoms. Two studies
included psychosocial support and nutritional counsel-
ling; however, programmes that offer additional support
have not been shown to prevent PTB.52 Four other
studies repeated digital cervical assessments, although
there has been no evidence of its effectiveness as a
screening test for PTB risk in average-risk pregnancies.53
Importantly, the studies of specialised care were con-
ducted in the late 1980s and 1990s, before the develop-
ment of new clinical interventions to prevent PTB such
as progesterone or use of cerclage, and before promis-
ing screening tests to predict PTB.54 In the UK and the
USA, recent reviews have advocated promising tests that
predict the risk of PTB, including the fetal ﬁbronectin
test (FFT),55 combined approaches using FFT and
Figure 3 Funnel plot comparing preterm birth (<37 weeks)
between pregnant women receiving alternative models of
antenatal care and those receiving routine care—data
adjusted for cluster design effect (ICC 0.002). ICC, intracluster
correlation coefficient; RR, risk ratios.
Figure 4 Forest plot comparing preterm birth (<37 weeks) outcome variation between midwife-led and specialised care for
alternative models of antenatal care versus routine care.
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transvaginal ultrasound scan for cervical length in symp-
tomatic women,56 as well as the FFT, absence of fetal
breathing movements, and cervical length within 48 h
and within 7 days of testing.57
Interventions in the majority of specialised care
studies were provided by specially trained staff, but little
information was provided regarding adherence or safe-
guard checks to ensure programme differentiation in
most of the studies. Late participant registration (middle
and end of second trimester or later) in half of the
studies might also have reduced the effectiveness of the
interventions since longer exposure to specialised care is
likely to be beneﬁcial. The issue that all specialised care
studies were conducted in the USA may potentially
affect generalisability of these results. The USA has a
health system wherein midwives were not be able to
provide midwife-led continuity of care. Antenatal care in
the USA is generally provided through care led by obste-
tricians, GPs, or both or shared among diverse health
professionals.58 Thus, specially trained nurses were the
main care providers in only three studies, and the level
of continuity of care was unclear. The extent to which
the reduced likelihood of PTB might be attributed to
the continuity of antenatal care models or the degree
and quality of relationships between women and their
healthcare providers will require further research. In
addition, the role of risk-scoring systems in the preven-
tion of PTB is currently unknown.59 While the Creasy
risk-scoring tool was commonly used to deﬁne women at
low or high risk of PTB, score systems differed across
trials, and the information regarding the cut-off used
was not consistently reported. This might have affected,
for example, the enrolment of women with relatively
low-risk scores, potentially leading to the
underenrolment of the women who had the most to
beneﬁt from the intervention.
Owing to the nature of the complex interventions, it
was recognised that clinical heterogeneity was sufﬁcient
to expect that the underlying effects varied among
studies. In fact, except for midwife-led studies, there was
substantial statistical heterogeneity within each subgroup
analysed. It is possible that women’s psychosocial, struc-
tural, and sociodemographic characteristics, deﬁned in
terms of risk characteristics (eg, maternal behaviours,
education, infections, stress or ethnic differences in gen-
etics) might have had a confounding inﬂuence on
PTBs.60 61 Midwifery continuity models of care have
been particularly valued by socially disadvantaged
women with difﬁcult access to health services,62 63 and
their experience of more empathic care, agency and
control64 may have an impact on PTB outcomes.
Worldwide, and particularly in the UK, there is an
increasing interest in ensuring that specialised antenatal
clinics offer midwifery continuity of care.65
In this review, there were limitations in the way mater-
nal satisfaction and economic costs were assessed and
reported in the eight studies examined. However, of the
specialist care studies, only two reported economic
aspects and only one reported maternal satisfaction. The
level of satisfaction with several aspects of antenatal care
appears to be higher in specialised care and midwife-led
continuity models than in routine care. Despite a lack of
consistency in estimating maternity care costs among the
included trials, the results of various economic evalu-
ation methods generally suggest a trend towards a cost-
saving effect in midwife-led continuity care models and
a higher cost of specialised care compared to routine
care.
Figure 5 Forest plot comparing preterm birth (<37 weeks) outcome variation between pregnant women at low and mixed risk of
complications for alternative models of antenatal care versus routine care.
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Quality of the evidence
The strengths of this review include the use of comprehen-
sive search strategies and the rigorous methods used for
the data synthesis. Despite the lack of restrictions regarding
publication date, country or language, all of the included
studies were written in English, published between 1989
and 2013, and conducted in high-income countries in dif-
ferent cultural and healthcare system settings.
The quality of the evidence in the 15 included studies
was mixed, and this could be linked to methodological
insufﬁciencies and substantial heterogeneity in some
studies. Figure 6 summarises the assessment of risk of
bias for individual trials. Compared with studies of
midwife-led continuity of care, studies of specialised care
were of lower quality. Most of these studies reported ges-
tational age at delivery, preterm labour or PTB with little
information regarding other outcomes of interest;
statistical power may not have been sufﬁcient to detect
signiﬁcant differences between subgroups. Only one
study used a quasi-randomised method, and the
methods used to conceal allocation were at unclear or
high risk of bias in four other studies in which the
women were randomised. The blinding methodology
was not clearly reported in half of the included studies,
and some of the included studies were at high risk of
bias in blinding of outcome. Findings of the cluster trial
were not adjusted for cluster design effect, and possible
design effects might have been taken into account for
PTB and low birthweight outcomes. Two midwife-led
continuity of care studies and four specialised care
studies reported no or insufﬁcient information on
incomplete outcome data, possibly affecting the quality
of the evidence. Even small losses might sometimes be
signiﬁcant, and the women who were most vulnerable to
adverse outcomes might have been over-represented
among those who were not followed up. Steps were
taken to minimise potential biases in the reviewing
process, including the two authors independently asses-
sing study eligibility, as well as data extraction and
meta-analysis.
AUTHORS’ CONCLUSIONS
Implications for practice and research
Our ﬁndings suggest that overall, alternative models of
antenatal care for all pregnant women are effective in
reducing PTB compared with routine care without any
evidence of adverse effects. No ﬁrm conclusions could be
drawn regarding the relative beneﬁts of the two models,
midwife-led continuity of care and specialised care.
However, because a few studies excluded women with sub-
stantial maternal disease, substance misuse or suicide
attempts during pregnancy, caution is needed when
applying these ﬁndings to pregnant women with the
above medical, mental and/or obstetric complications.
Substantial progress is still required in the research
and implementation of the evidence.66 A better under-
standing of the multicausal and complex nature of PTB
might help to develop an effective framework for trials
of more recent interventions in reducing the rate of
PTB. Future research will require an exploration of
whether the midwife-led continuity model of antenatal
care or the degree and quality of relationship between
the woman and the care provider might be responsible
for the signiﬁcant impact on PTB. In addition, more
research on effective risk-screening tools to predict
preterm labour and a data set of core outcome measures
to be collected67 would be useful for making trial com-
parisons and for further reviews of similar studies.
Future studies should consider treating gestational age
as a continuum rather than a dichotomy since this
better reﬂects the biological processes which do not
change markedly at 37 weeks. Further, the analysis of
gestational age as a continuous variable provides more
Figure 6 Risk of bias summary showing review author’s
judgements about each risk of bias domain in included
studies. Randomised clinical trials are listed alphabetically by
author name.
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statistical power and allows ﬁner differences to be
detected.68
In addition, studies of complex interventions such as
antenatal care models should include standardised
reporting of the intervention69 and implementation
ﬁdelity.70 Further research will be required to develop
reliable and valid methods of assessing women’s satisfac-
tion and well-being, as well as standard approaches to
estimate relative antenatal costs and beneﬁts to women,
families, societies, and the health systems.
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